FDA product code · General hospital
Heparin, Vascular Access Flush
7 FDA decisions since 2003. 27 recalls name this code, 0 of them Class I. The most-cited predicate is K023740, named by 3 later devices.
Enhance the performance of intravascular catheters, to maintain patency of the vascular catheter when it is not in use.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly Download the data (CSV)
Twenty years of NZW at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.
FDA decisions per year · NZW
1in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · NZW
Too few NZW 510(k)s in any year since 2007 to give a median.
Recalls per year · NZW
1in 2014
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · NZW
11in 2025
MAUDE reports naming product code NZW, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 21 |
| 2008 | 0 | — | 22 | 291 |
| 2009 | 1 | — | 0 | 122 |
| 2010 | 2 | — | 3 | 194 |
| 2011 | 0 | — | 0 | 33 |
| 2012 | 0 | — | 1 | 9 |
| 2013 | 0 | — | 0 | 15 |
| 2014 | 1 | — | 1 | 8 |
| 2015 | 0 | — | 0 | 5 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 1 | — | 0 | 3 |
| 2018 | 0 | — | 0 | 19 |
| 2019 | 0 | — | 0 | 19 |
| 2020 | 0 | — | 0 | 3 |
| 2021 | 0 | — | 0 | 10 |
| 2022 | 0 | — | 0 | 14 |
| 2023 | 0 | — | 0 | 9 |
| 2024 | 0 | — | 0 | 10 |
| 2025 | 0 | — | 0 | 11 |
| 2026 | 0 | — | 0 | — |
Planning a device in NZW? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportRelated product codes
Other codes under 21 CFR 880.5200.